Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U4HM
|
|||
Former ID |
DIB021074
|
|||
Drug Name |
TPMPA
|
|||
Synonyms |
(1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
![]() |
Download2D MOL |
||
Formula |
C6H12NO2P
|
|||
Canonical SMILES |
CP(=O)(C1=CCNCC1)O
|
|||
InChI |
1S/C6H12NO2P/c1-10(8,9)6-2-4-7-5-3-6/h2,7H,3-5H2,1H3,(H,8,9)
|
|||
InChIKey |
MFUKVPOVVKKLRQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 182485-36-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA(A) receptor rho1 (GABRR1) | Target Info | Antagonist | [2] |
GABA(A) receptor rho2 (GABRR2) | Target Info | Antagonist | [3] | |
GABA(A) receptor rho3 (GABRR3) | Target Info | Antagonist | [4] |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4328). | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 420). | |||
REF 3 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 421). | |||
REF 4 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 422). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.